Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
01:56pm, Saturday, 26'th Jun 2021
New York, New York--(Newsfile Corp. - June 26, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investo
San Francisco, California--(Newsfile Corp. - June 25, 2021) - Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud cl
BENSALEM, Pa., June 25, 2021 /PRNewswire/ -- Law Offices of Howard G.
Los Angeles, California--(Newsfile Corp. - June 25, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. (
New Orleans, Louisiana--(Newsfile Corp. - June 24, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have
New York, New York--(Newsfile Corp. - June 24, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Ch
Los Angeles, California--(Newsfile Corp. - June 24, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. (
New York, New York--(Newsfile Corp. - June 23, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between Novembe
RADNOR, Pa., June 23, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (
San Francisco, California--(Newsfile Corp. - June 23, 2021) - Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud cl
Is ChemoCentryx a Buy?
07:18am, Wednesday, 23'rd Jun 2021
Next month is sure to be a big one for the company, with the FDA slated to make a decision on its most advanced drug, avacopan.
CCXI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving ChemoCentryx, Inc.
05:24am, Wednesday, 23'rd Jun 2021
New York, New York--(Newsfile Corp. - June 23, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased ChemoCentryx, Inc. (NASDA
Radnor, Pennsylvania--(Newsfile Corp. - June 22, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) ("ChemoCentryx") investors that a securities fra
New York, New York--(Newsfile Corp. - June 22, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ChemoCentryx, Inc. (NASDAQ: CCXI) allegi
New York, New York--(Newsfile Corp. - June 22, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Ch
